English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

OBJECTIVESMetabolic syndrome and diabetes prevalence varies according to chosen definition, as well as with the geographical and ethnical group. No studies are available in Portuguese patients with suspected coronary artery disease. We analysed metabolic syndrome and diabetes prevalence in this specific population and compared definitions.METHODSThe study included 300 patients, with a mean age of 64 ± 9 years, 59% males, admitted for an elective coronary angiography and we excluded patients with previous cardiac disease. Metabolic syndrome and diabetes prevalence was obtained.RESULTSThe adjusted prevalence of metabolic syndrome was found to be 39.3% (NCEP-ATP III criteria), 53.8% (IDF criteria) and 48.4% (AHA/NHLBI). Adjusted prevalence of diabetes was 14.8% by the previous ADA definition and 36.4% with the new definition. Global agreement between metabolic syndrome definitions was 45.3%, with the highest value between AHA/NHLBI and NCEP-ATP III (Kappa 0.821). Metabolic syndrome prevalence was highly age-dependent in both genders and more prevalent in females. Diabetes prevalence was also age-dependent, with similar prevalence in both genders. The most frequent metabolic syndrome component was hypertension, followed by abdominal obesity, raised glucose, low HDL-cholesterol and finally increased triglycerides. It is also important to mention that 60% of the patients were under lipid-lowering treatment (56.6% with statins, 1.7% with fibrates and 1.7% with both). The most significant difference between genders for metabolic syndrome components is the high prevalence of abdominal obesity in females.CONCLUSIONSIn this high-risk population, metabolic syndrome prevalence is high, with similar diabetes prevalence compared with general population epidemiological studies.

Prevalence of metabolic syndrome and diabetes on a high-risk population with suspected coronary artery disease.